MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Diagnostic value of striatal [18F]-FP-DTBZ PET in Parkinson’s disease

X. Liu, S. Liu, O. Barret, G. Tamagnan, H. Qiao, T. Song, C. Piu, J. Lu (Beijing, China)

Meeting: 2022 International Congress

Abstract Number: 163

Keywords: Parkinsonism, Positron emission tomography(PET), Vesicle monamine transporter(VMAT2)

Category: Parkinson's Disease: Neuroimaging

Objective: To detect the difference of dopaminergic integrity between PDs and healthy controls (HC) using [18F]-FP-DTBZ PET in vivo and to obtain the diagnostic value of standardized uptake value ratios (SUVRs) using Receiver Operating Characteristic (ROC) curve.

Background: [18F]-FP-DTBZ has been proven as a biomarker for quantification the density of presynaptic vesicular monoamine transporter 2 (VMAT2).

Method: A total of 34 PD and 31 HC participants were enrolled in the PET/MR derivation cohort; while 89 PD and 18 HC participants were recruited in the PET/CT validation cohort. The Hoehn-Yahr Scale and the third part of the MDS-Unified Parkinson’s Disease Rating Scale (MDSUPDRS-III) were used to evaluate the disease staging and severity. All assessment and PET scanning were performed in drug-off states. We segmented the striatum of each side into five subregions as following: caudate, anterior dorsal putamen, anterior ventral putamen, posterior dorsal putamen, posterior ventral putamen using automatic pipeline built with the PMOD software (version 4.105). The SUVRs of the targeted subregions were calculated using bilateral occipital cortex as the reference region.

Results: ROC curve showed that the diagnostic value of contralateral posterior dorsal putamen (SUVR = 3.43) had the best diagnostic accuracy (AUC =0.973; P < 0.001), with a sensitivity of 97.1% (95%CI: 82.9-99.8%), specificity of 100% (95%CI:86.3-100%), positive predictive value of 100% (95%CI: 87.0-100%), negative predictive value of 96.9% (95%CI: 82.0-99.8%) and an accuracy of 98.5% for the diagnosis of PD. Blind validation was done using the PET/CT cohort, and participants with a SUVR of the posterior dorsal putamen less than 3.43 were defined as PD. Kappa test showed a consistency of 0.933 (P < 0.001) between clinical diagnostic and imaging diagnosis, with a sensitivity of 98.9%(95%CI:93.0-99.9%),specificity of 94.4%(95%CI:70.6-99.7%), positive predictive value of  98.9%(95%CI:93.0-99.9%), negative predictive value of 94.4%(95%CI:70.6-99.7%), and a diagnostic accuracy of 98.1%.

Conclusion: Our results showed the SUVR of 3.43 in the posterior dorsal putamen could effectively distinguish PD participants from HC.

To cite this abstract in AMA style:

X. Liu, S. Liu, O. Barret, G. Tamagnan, H. Qiao, T. Song, C. Piu, J. Lu. Diagnostic value of striatal [18F]-FP-DTBZ PET in Parkinson’s disease [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/diagnostic-value-of-striatal-18f-fp-dtbz-pet-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/diagnostic-value-of-striatal-18f-fp-dtbz-pet-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley